Basic Brand Levitra Information

• INN (International Nonproprietary Name): Vardenafil
• Brand Names Available In United Kingdom: Levitra; Staxyn (Orally Disintegrating Tablet listed in other markets); generics marketed as Vardenafil Teva, Vardenafil Sandoz, Vardenafil Ratiopharm
• ATC Code: G04BE09 — Phosphodiesterase-5 (PDE5) inhibitor for erectile dysfunction
• Forms & Dosages: Film-coated tablets 5 mg, 10 mg, 20 mg; Orally disintegrating tablets (ODT) 10 mg
• Manufacturers In United Kingdom: Original marketing authorisation holder Bayer Schering Pharma; EU generics supplied by Sandoz, Teva and Accord Healthcare (local availability varies)
• Registration Status In United Kingdom: Registered as a prescription-only medicine and aligned with EMA approvals; MHRA pharmacovigilance applies
• OTC / Rx Classification: Prescription-only (Rx)

Research Findings — UK & EU

Clinicians ask whether vardenafil offers meaningful advantages over other PDE5 inhibitors in routine care.

Recent UK and EU reports from 2022–2025 summarise comparative effectiveness, onset and safety surveillance for vardenafil in adult men with erectile dysfunction.

Regulatory summaries confirm EMA approval and ongoing prescription status across the EU, with MHRA pharmacovigilance used for UK safety reporting.

Several comparator trials and pooled meta-analyses of PDE5 inhibitors included vardenafil as a treatment arm, with clinically meaningful endpoints such as change in IIEF‑EF score and patient‑reported improvement used consistently.

UK cohort data from 2022–2025 indicated comparable efficacy to sildenafil in IIEF‑EF improvements and some evidence of a faster onset with ODT formulations in selected patients.

Data highlights — adverse events and discontinuation:

• Adverse-event rates across post‑marketing surveillance were consistent with known PDE5 inhibitor class effects.
• Discontinuation was commonly driven by lack of efficacy or tolerability rather than unexpected safety signals.

Clinical Effectiveness In The UK

Patients want to know how vardenafil performs in NHS practice compared with trial settings.

Real‑world audits from sexual health clinics and NHS prescribing data show that vardenafil (Levitra and generics) is commonly prescribed by GPs, sexual health services and private clinics for episodic use.

Typical NHS effectiveness measures use IIEF‑EF mean change and responder rates collected via clinic follow‑up or NHS patient portals.

• Patient‑centred outcomes recorded include speed of onset, partner satisfaction and adherence.
• Common reasons for switching between PDE5 inhibitors are poor efficacy, side effects or cost.
• Vardenafil’s as‑needed dosing fits the episodic use patterns commonly seen in primary care settings.

IIEF

International Index of Erectile Function, commonly using the Erectile Function domain (IIEF‑EF).

Responder Rate

Proportion of patients achieving predefined improvement thresholds on IIEF‑EF or reporting meaningful benefit.

Evidence gaps remain in long‑term adherence and management of polypharmacy in patients with multimorbidity.

Indications & Expanded Uses

Patients frequently ask what vardenafil is licensed for and what uses are seen in private practice.

MHRA and EMA approve vardenafil for erectile dysfunction in adult men only.

Vardenafil is a prescription‑only medicine and paediatric use is not indicated.

• Approved Uses: Erectile dysfunction in adult men (as needed dosing).
• Off‑Label / Private Clinic Practices: Low‑dose tailored regimens combined with psychosexual therapy in selected patients; dosing timing variations with ODT formulations.
• Not Indicated: Paediatric use and routine treatment of pulmonary hypertension (other PDE5 agents are preferred for that condition).

Standard dosing follows the approved regimen: start 10 mg, adjust to 5–20 mg based on response and tolerability, with ODT 10 mg not interchangeable mg‑for‑mg with tablets.

Clinical governance in NHS settings expects documentation of informed consent when prescribing off‑label.

Composition & Brand Landscape

Pharmacies and prescribers need clarity on which brands and generics are available locally.

Original manufacturer is Bayer Schering Pharma, marketed as Levitra in many EU countries in blister packs of 2, 4, 8 and 12 film‑coated tablets.

Generics are widely available from Sandoz, Teva and Accord Healthcare and are commonly dispensed by community pharmacies and e‑pharmacies.

• Packaging commonly uses blister packs to protect stability.
• Boots, LloydsPharmacy and Superdrug commonly supply vardenafil on private prescription; many online pharmacies dispense generics.
• Brand availability varies by market; Levitra brand is discontinued in the US but continues to be present across parts of the EU.

Contraindications & Special Precautions

Safety screening before supply is essential to prevent serious interactions and harms.

Absolute contraindications include concurrent use with nitrates, known hypersensitivity to vardenafil or excipients, and severe hepatic or renal impairment where higher doses would be unsafe.

• Absolute Contraindications: Concurrent nitrates (including recreational poppers), hypersensitivity to vardenafil, severe hepatic impairment, severe renal impairment where dosing cannot be safely adjusted, specific excipient‑related hereditary conditions.
• Relative Cautions: Unstable cardiovascular disease, recent myocardial infarction or stroke, anatomical penile deformities, retinitis pigmentosa, concomitant alpha‑blocker therapy.

Pharmacists should emphasise MHRA Yellow Card reporting for suspected adverse reactions and conduct medication reviews in patients with polypharmacy.

Dosage Guidelines

Patients commonly ask how much to take and when to take it.

The usual starting dose is 10 mg taken approximately 25–60 minutes before sexual activity, adjusted to 5 mg or 20 mg depending on effectiveness and tolerability.

ODT preparations are a fixed 10 mg dose and are not interchangeable on a mg‑for‑mg basis with film‑coated tablets.

• Practical tips: take on a lighter stomach for faster onset and avoid high‑fat meals that delay absorption.
• Checklist for pharmacists: confirm nitrates, alpha‑blockers, liver/kidney status and other interacting medicines.

Drug, Food & Safety Interactions

Interaction checks are a critical step at dispensing.

Concurrent nitrates represent an absolute contraindication due to risk of severe hypotension.

Strong CYP3A4 inhibitors such as ritonavir or clarithromycin can increase vardenafil exposure and may require dose adjustment or avoidance.

• Major Interactions: Nitrates — do not co‑administer.
• Significant Interactions: Strong CYP3A4 inhibitors (clarithromycin, ritonavir) — avoid or reduce dose; grapefruit juice can increase exposure.
• Caution With Alpha‑Blockers: Orthostatic hypotension risk — start at lower alpha‑blocker dose or separate dosing and monitor blood pressure.

Pharmacists should check OTCs, herbal supplements and recreational drugs during counselling and report suspected interaction ADRs to the MHRA Yellow Card scheme.

Cultural Perceptions & Patient Habits In The UK

Many men worry about stigma and discretion when seeking treatment for erectile dysfunction.

Patients often prefer initial conversations with a pharmacist or via NHS patient portals before seeing a GP or visiting a private clinic.

Telemedicine and online pharmacies have grown in popularity, offering electronic prescriptions and discreet delivery.

• Common Patient Concerns: efficacy, side effects, cost and discretion.
• Help‑Seeking Patterns: NHS 111 for triage, GP for repeat prescriptions, private clinics for faster access and tailored counselling.
• Pharmacist Role: privacy, quick advice and signposting to sexual health clinics or NHS resources.

Anonymous forum discussions on patient.info and other UK sites reflect a desire for clear dosing advice and reassurance about safety when using vardenafil alongside other medicines.

Availability & Pricing Patterns

Access is usually by NHS prescription or private script, and supply routes affect patient cost.

England charges per NHS item, while Scotland, Wales and Northern Ireland generally provide free prescriptions, influencing whether patients choose NHS or private routes.

Boots, LloydsPharmacy and Superdrug commonly supply vardenafil on private prescription, and many reputable online pharmacies dispense generics to UK addresses.

In our online pharmacy, brand levitra is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Pharmacies should monitor MHRA supply alerts for shortages and document any substitutions for audit purposes.

Comparable Medicines & Prescribing Preferences

Clinicians often compare vardenafil with sildenafil and tadalafil to match patient needs.

• Pros For Vardenafil: generally similar efficacy to other PDE5 inhibitors and potential faster onset with ODT in some users.
• Cons For Vardenafil: variation in availability by brand and ODT bioavailability differences to consider.
• Prescribing Preference: GPs and urologists trial different PDE5 inhibitors to find the best balance of efficacy, tolerability and patient preference.

FAQ — Common NHS Patient Questions

Dosing reminders: start 10 mg, maximum once daily, and ODT 10 mg is not interchangeable with tablet strengths.

For reporting suspected adverse reactions, patients should use the MHRA Yellow Card system.

Guidelines For Proper Use & Pharmacist Counselling

Pharmacists should run a brief screening checklist before supplying vardenafil.

Screen for nitrates, cardiac history, hepatic and renal impairment and review concomitant medications for CYP3A4 inhibitors and alpha‑blockers.

Offer dosing advice: take 25–60 minutes before activity, avoid high‑fat meals for faster onset and do not exceed once daily dosing.

Explain common side effects such as headache, flushing and nasal congestion and advise when to seek urgent help for priapism or sudden visual loss.

• Do: check prescriptions, counsel on interactions and signpost sexual health clinics for ongoing care.
• Don't: co‑supply with nitrates or ignore reports of chest pain after dosing.

Storage advice: keep below 25°C in original packaging and seek emergency care for overdose, severe hypotension or priapism.

Document dispensing in NHS records and report suspected ADRs to the MHRA Yellow Card scheme.

Delivery Across United Kingdom